Phase 2 Completed N=94 Randomized Triple-blind Treatment

Safety and Efficacy Study of Topical Cantharidin for the Treatment of Molluscum Contagiosum

Molluscum Contagiosum

Source: ClinicalTrials.gov NCT02665260 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

May 2017

Primary outcomePrimary: Number of Subjects Who Achieve Complete Clearance at 6 Weeks — 10; 7; 2; 3 Participants

Summary

The purpose of this study is to determine if cantharidin is a safe and effective treatment for molluscum contagiosum in kids

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Subjects Who Achieve Complete Clearance at 6 Weeks	10; 7; 2; 3; 14; 16	—
SECONDARY Number of Subjects Who Experienced an Adverse Event	0; 0; 0; 0; 23; 24	—

Eligibility Criteria

Inclusion Criteria

2-17years
Healthy
<50 molluscum contagiosum lesions

Exclusion Criteria

Immunosuppressed
Oral corticosteroids
Sexually active/pregnant

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02665260). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.